Active: new fund Nov 2025 Verified 5 Nov 2026
Sofinnova Partners
Life sciences venture capital firm based in Paris, London and Milan that invests from seed to later stage in biopharma, medtech, digital medicine and industrial biotech, including through its own company-building accelerators.
- Type
- VC firm
- Location
- France (London office)
- Stages
- Seed, Series A, Series B, Growth
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences, Fintech, Agritech, Industrial, Deep tech
- Fund size / AUM
- Over EUR 4 billion under management (own site)
- Portfolio mix
- Biotech and pharma 88%; Consumer products 7%; Medtech and digital health 5% (n=30)
- Website
- sofinnovapartners.com
Contacts on file
For Sofinnova Partners, the paid file holds: 8 named decision-makers with roles; how to pitch (the route the firm publishes).
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
T-TherapeuticsAlethio TherapeuticsBrightHeartAbivaxAAVantgarde Bio
Sources
- sofinnovapartners.com/
- sofinnovapartners.com/team
- sofinnovapartners.com/portfolio
- sofinnovapartners.com/news
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 55 lists
Industrial tech investors in London (22)Series B agritech investors (24)Series B industrial tech investors (40)Biotech investors in London (42)Growth-stage agritech investors (46)Industrial tech investors in Europe (60)Agritech investors in Europe (63)Series A agritech investors (65)Deep tech investors in London (66)Series B biotech investors (73)Venture capital firms in France (81)Growth-stage industrial tech investors (81)Biotech investors in Europe (89)Seed agritech investors (97)Growth-stage biotech investors (109)Series B deep tech investors (113)Series A industrial tech investors (113)Fintech investors in London (113)Healthtech investors in London (113)Series B investors in Europe (117)Series B fintech investors (127)Agritech investors (137)Fintech investors in Europe (140)Venture capital firms in London (149)Series A biotech investors (153)Series B healthtech investors (160)Startup investors in France (189)Growth-stage deep tech investors (191)Growth-stage fintech investors (214)Startup investors in London (239)Seed industrial tech investors (249)Growth-stage investors in Europe (276)Healthtech investors in Europe (291)Series A deep tech investors (293)Series A fintech investors (294)Deep tech investors in Europe (299)Seed biotech investors (300)Growth-stage healthtech investors (316)Series A investors in Europe (329)Series B investors (339)Industrial tech investors (387)Series A healthtech investors (401)Venture capital firms in Europe (412)Biotech investors (484)Seed investors in Europe (543)Seed deep tech investors (555)Seed fintech investors (584)Growth-stage investors (705)Startup investors in Europe (725)Deep tech investors (763)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)